| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC | 10.6% | +35% | $49,037,031 | +$24,518,517 | 14,814,813 | +1% | Invus Public Equities, L.P. | 30 Jun 2025 |
| Samsara BioCapital, L.P. | 7.4% | +25% | $56,191,805 | +$22,319,746 | 13,540,194 | +65.9% | Srinivas Akkaraju | 17 Nov 2025 |
| Andera Partners | 8.8% | +32.9% | $40,700,736 | +$20,350,370 | 12,296,295 | +1% | Andera Partners | 30 Jun 2025 |
| BIOTECHNOLOGY VALUE FUND L P | 4.99% | -18.5% | $39,714,931 | +$4,251,111 | 9,569,863 | +12% | BVF PARTNERS L P/IL | 17 Nov 2025 |
| New Enterprise Associates 17, L.P. | 6% | $31,315,238 | 8,350,730 | New Enterprise Associates 17, L.P. | 07 May 2025 | |||
| Sofinnova Crossover I | 7.2% | $29,221,151 | 7,792,307 | Sofinnova Crossover I SLP | 31 Dec 2024 | |||
| Yiheng Capital Management, L.P. | 5.46% | -35.6% | $43,962,416 | +$18,899,084 | 7,597,148 | +75.4% | Yiheng Capital Partners, L.P. | 30 Sep 2025 |
| PERCEPTIVE ADVISORS LLC | 4.99% | -13.5% | $42,246,764 | +$10,098,434 | 7,300,666 | +31.4% | Perceptive Advisors LLC | 30 Sep 2025 |
| Broqua Pierre | 4.3% | $15,365,625 | 4,097,500 | Pierre Broqua | 31 Dec 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 5,106,787 | $29,415,940 | +$1,094,859 | $5.79 | 15 |
| 2025 Q2 | 4,928,159 | $15,667,628 | +$214,859 | $3.19 | 12 |
| 2025 Q1 | 4,860,363 | $12,214,319 | -$1,721,340 | $2.94 | 8 |
| 2024 Q4 | 5,447,098 | $11,663,912 | +$1,275,982 | $2.14 | 7 |
| 2024 Q3 | 4,851,351 | $9,059,439 | -$1,414 | $1.86 | 7 |
| 2024 Q2 | 4,845,553 | $14,461,203 | -$19,438 | $2.99 | 7 |
| 2024 Q1 | 4,849,836 | $17,555,978 | -$52,773 | $3.62 | 8 |
| 2023 Q4 | 4,860,874 | $21,917,529 | +$26,077 | $4.52 | 8 |
| 2023 Q3 | 4,855,354 | $20,589,732 | +$102,187 | $4.2 | 7 |
| 2023 Q2 | 4,830,074 | $19,513,567 | -$1,019,078 | $4.04 | 8 |
| 2023 Q1 | 5,129,875 | $18,275,932 | +$1,089,878 | $3.64 | 8 |
| 2022 Q4 | 4,812,252 | $21,919,774 | -$19,722,477 | $4.44 | 6 |
| 2022 Q3 | 8,933,248 | $33,067,000 | -$1,003,809 | $3.86 | 7 |
| 2022 Q2 | 9,109,429 | $51,761,000 | +$29,343,302 | $5.77 | 10 |
| 2022 Q1 | 3,934,328 | $45,020,000 | +$2,060,118 | $11.4 | 9 |
| 2021 Q4 | 3,755,787 | $51,299,000 | +$608,002 | $13.66 | 10 |
| 2021 Q3 | 3,708,525 | $52,500,000 | +$30,368,738 | $14.16 | 11 |
| 2021 Q2 | 1,564,469 | $21,328,000 | -$848,745 | $13.58 | 14 |
| 2021 Q1 | 1,623,116 | $23,833,940 | -$15,643,566 | $14.69 | 13 |
| 2020 Q4 | 2,733,996 | $39,206,000 | -$22,116,536 | $14.5 | 15 |
| 2020 Q3 | 4,021,314 | $47,498,000 | +$47,498,000 | $11.81 | 17 |